Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the DCCT

JAMA

Volumn 280, Issue 2, 1998, Pages 140-146

  Purnell, Jonathan Q ^a,f   Hokanson, John E ^a,b   Marcovina, Santica M ^a   Steffes, Michael W ^d,e   Cleary, Patricia A ^c,e   Brunzell, John D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Diabet Contr Complications T

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; WEIGHT GAIN;

EID: 0032496876     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.2.140     Document Type: Article

References (27)

1. Brunzell JD. Obesity and risk for cardiovascular disease. In: Greenwood MRC, ed. Contemporary Issues in Clinical Nutrition, Obesity. New York, NY: Churchill Livingston Inc; 1983:3-16.
2. Laakso M, Pyorala K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism. 1990;39:117-122.
3. The Diabetes Control and Complications Trial Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care. 1988;11:567-573.
4. Wing RR, Klein R, Moss SE. Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes. Diabetes Care. 1990;13:1106-1109.
5. The Diabetes Control and Complications Trial Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995; 18:1415-1427.
6. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol. 1995;75:894-903.
7. Purnell JQ, Marcovina SM, Hokanson JE, et al. Levels of Lp(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM: results from follow-up in the Diabetes Control and Complications Trial. Diabetes. 1995;44:1218-1226.
8. Stuhldreher WL, Orchard TJ, Ellis D. The association of waist-hip ratio and risk factors for development of IDDM complications in an IDDM adult population. Diabetes Res Clin Pract. 1992; 17:99-109.
9. Brunzell JD, Chait A. Diabetic dyslipidemia-pathology and treatment. In: Porte D Jr, Sherwin J, eds. Ellenberg and Rifkin's Diabetes Mellitus. East Norwalk, Conn: Appleton & Lange Inc; 1997:1077-1098.
10. Dorman JS, Laport RE, Kuller LH, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study: mortality results. Diabetes. 1984;33:271-276.
11. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987;59:750-755.
12. Koivisto VA, Stevens LK, Mattock M, et al. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care. 1996;19:689-697.
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
14. US Department of Health and Human Services. The Prevalence Study. Vol. 1. Bethesda, Md: Public Health Service, National Institutes of Health, 1980.
15. Metropolitan height and weight tables. Stat Bull Metrop Life Ins Co. 1993;43:410-418.
16. The Diabetes Control and Complications Trial Research Manual of Operations. Springfield, Va: US Dept of Commerce, National Technical Information Service, 1993; Publication 93-183382.
17. The Diabetes Control and Complications Trial Research Group. The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes. 1986;35:530-545.
18. Marcovina SM, Albers JJ, Gabel B, Koshinsky ML, Guar VP. Effect of the number of apolipoprotein (a) kringle 4 domains on immunochemical measurements of lipoprotein (a). Clin Chem. 1995;41: 246-255.
19. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B, IV: comparability of apolipoprotein B values by use of International Reference Material. Clin Chem. 1994; 40:586-592.
20. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64:1169-1173.
21. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed marker for coronary artery disease risk. Circulation. 1990;82:495-506.
22. Kuczmarski R, Flegal K, Campbell S, Johnson C. Increasing prevalence of overweight among US adults. JAMA. 1994;272:205-211.
23. Gardner DC, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875-881.
24. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
25. American Diabetes Association. Detection and management of lipid disorders in diabetes. Diabetes Care. 1996;19(suppl 1):S96-S102.
26. Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD. The visceral adiposity syndrome in Japanese-American men. Obes Res. 1994;2:364-371.
27. Tchernof A, Lamarche B, Prud'Homme D, et al. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 1996;19: 629-637.